BiotechTube

ASP0113 + Placebo

Phase 2Completed
0 watching 0 views this week⚡ Active
52
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Kidney Transplantation Cytomegalovirus (CMV) Negative Recipients

Conditions

Kidney Transplantation Cytomegalovirus (CMV) Negative Recipients

Trial Timeline

Nov 20, 2013 → Nov 5, 2020

NCT ID
NCT01974206

About ASP0113 + Placebo

ASP0113 + Placebo is a phase 2 stage product being developed by Astellas Pharma for Kidney Transplantation Cytomegalovirus (CMV) Negative Recipients. The current trial status is completed. This product is registered under clinical trial identifier NCT01974206. Target conditions include Kidney Transplantation Cytomegalovirus (CMV) Negative Recipients.

Hype Score Breakdown

Clinical
17
Activity
12
Company
10
Novelty
5
Community
5

Clinical Trials (3)

NCT IDPhaseStatus
NCT02103426Phase 1Completed
NCT01974206Phase 2Completed
NCT01877655Phase 3Completed

Competing Products

20 competing products in Kidney Transplantation Cytomegalovirus (CMV) Negative Recipients

See all competitors
ProductCompanyStageHype Score
Empagliflozin + Matching placeboEli LillyPhase 3
77
Baricitinib + PlaceboEli LillyPhase 2
52
SGLT2 inhibitorEli LillyPre-clinical
23
LY2623091 + EplerenoneEli LillyPhase 2
52
Telmisartan/Rosuvastatin 40/10mg + Telmisartan 40mgYuhanApproved
85
TacrolimusAstellas PharmaApproved
85
RituximabAstellas PharmaPhase 2
52
Prograf + MR4Astellas PharmaPhase 3
77
basiliximab + rabbit anti-thymocyte globulin + tacrolimus + alemtuzumab + mycophenolate mofetil + steroidsAstellas PharmaApproved
85
Tacrolimus, modified releaseAstellas PharmaPhase 3
77
Tacrolimus granulesAstellas PharmaApproved
85
roxadustatAstellas PharmaPhase 3
77
Tacrolimus immediate-release formulation + Tacrolimus prolonged-release formulation + Induction therapy + Mycophenolic acid drugs + CorticosteroidsAstellas PharmaApproved
85
ASP1128 + PlaceboAstellas PharmaPhase 2
52
FK506MR + Prograf + Mycophenolate Mofetil + Methylprednisolone + PrednisoloneAstellas PharmaPhase 3
77
MMF (Cellcept) and Steroids + Tacrolimus (Prograf)Astellas PharmaApproved
85
ASP1585Astellas PharmaPhase 3
77
Alefacept + tacrolimus + basiliximab + mycophenolate mofetil + CorticosteroidsAstellas PharmaPhase 2
52
Advagraf + Mycophenolate Mofetil + Simulect + CorticosteroidsAstellas PharmaApproved
85
tacrolimusAstellas PharmaApproved
85

Other Products from Astellas Pharma

Tacrolimus, Prograf®Approved
85
micafungin + voriconazoleApproved
85
mirabegron + solifenacinApproved
85
Zolpidem (Myslee®) + placeboApproved
85
TacrolimusApproved
85